Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Dublin ,Ireland ,Colorado ,United States ,Japan ,Israel ,Argentina ,Brazil ,Boston ,Massachusetts ,Saudi Arabia ,Colombia ,Canada ,Rory Nealon ,Hypercholesterolaemia Ho ,Joe Wiley ,Hanna Bruckner ,Tracy Cunningham ,Tim Mccarthy ,Lifesci Advisors ,University Of Colorado School Medicine ,European Commission ,Department Of Dermatology ,Society For Pediatric Dermatology ,Amryt Presents New Analyses ,Epidermolysis Bullosa ,Pediatric Dermatology ,Chief Medical Officer ,Colorado School ,Harper Price ,Homozygous Familial Hypercholesterolaemia ,Transient Permeability Enhancer ,Covid 19 ,Health ,Business ,Lifestyle ,Globe Newswire ,